ProHance ProHance® is a macrocyclic, non-ionic gadolinium-based contrast agent, characterized by very low osmolality and viscosity.

Iomeron Iomeron® is a non-ionic, monomeric, iodine contrast agent for radiology.

Distributors list Distributors list

Data protection Data Protection  

Cookie Policy Cookie Policy

Search Search page

ファーマコビジランス​ Pharmacovigilance is a system concerned with identifying, assessing, understanding and preventing adverse reactions as well as any other problems associated with taking medicines, with the aim to improve the treatment and safety of patients and better the public health.

Our president Diana Bracco, born in Milan, is President and CEO of the Bracco Group, a healthcare multinational and world leader in imaging diagnostics with a consolidated turnover of over 1.7 billion euros, around 3,700 employees, and a portfolio of over 2,500 patents. Founded in 1927 by Elio Bracco, the pharmaceutical company annually invests 10% of its imaging diagnostics turnover in research and development.

HSE Policy The Health, Safety, and Environment (HSE) Policy conveys the principles of the Bracco Group on health, safety, and environmental matters.

Transparency The Bracco Group is proud to collaborate with many Healthcare Professionals and Healthcare Organizations to support their activities and to disseminate scientific information.